Home Current Issue Previous Issues Publish Ahead-of-Print Collections For Authors Journal Info
Skip Navigation LinksHome > July 2012 - Volume 34 - Issue 5 > Cardiac Failure 30 Years After Treatment Containing Anthracy...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e3182532078
Clinical and Laboratory Observations

Cardiac Failure 30 Years After Treatment Containing Anthracycline for Childhood Acute Lymphoblastic Leukemia

Goldberg, John M. MD*,†,‡; Scully, Rebecca E. BA*,§; Sallan, Stephen E. MD; Lipshultz, Steven E. MD*,†,‡

Collapse Box

Abstract

In 1977, a 5-year-old girl diagnosed with acute lymphoblastic leukemia was treated on Dana-Farber Cancer Institute Childhood Acute Lymphoblastic Leukemia Protocol 77-01, receiving a cumulative doxorubicin dose of 465 mg/m2, cranial radiation, and other drugs. After being in continuous complete remission for 34 months, she developed heart failure and was treated with digoxin and furosemide. At 16 years of age, she was diagnosed and treated for dilated cardiomyopathy. Over the years, she continued to have bouts of heart failure, which became less responsive to treatment. At 36 years of age, she received a heart transplant. Six months later, she stopped taking her medications and suffered a sudden cardiac death.

© 2012 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us

Twitter
twitter.com/JPHOonline

For additional oncology content, visit LWW Oncology Journals on Facebook.